Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. Loza
Breakpoints for Predicting Pseudomonas Aeruginosa Susceptibility to Inhaled Tobramycin in Cystic Fibrosis Patients: Use of High-Range Etest Strips
Journal of Clinical Microbiology
Microbiology
Right-Sided Endocarditis Caused by Staphylococcus Aureus in Drug Abusers
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
The Susceptibility of Pseudomonas Aeruginosa Strains From Cystic Fibrosis Patients to Bacteriophages
PLoS ONE
Multidisciplinary
The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas Aeruginosa Infection in Non-Cystic Fibrosis Bronchiectasis
Journal of Aerosol Medicine and Pulmonary Drug Delivery
Pulmonary
Respiratory Medicine
Pharmacology
Pharmaceutical Science
Immunization of Noncolonized Cystic Fibrosis Patients Against Pseudomonas Aeruginosa
Journal of Infectious Diseases
Infectious Diseases
Allergy
Immunology
Eradication of Pseudomonas Aeruginosa in Cystic Fibrosis
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Treatment of Pseudomonas Aeruginosa Colonisation in Cystic Fibrosis.
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
In Vitro Activity of Aztreonam Combined With Tobramycin and Gentamicin Against Clinical Isolates of Pseudomonas Aeruginosa and Pseudomonas Cepacia From Patients With Cystic Fibrosis.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Pseudomonas Aeruginosa in Cystic Fibrosis: A Chronic Cheater
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Synergistic Activity of a Short Lipidated Antimicrobial Peptide (lipoAMP) and Colistin or Tobramycin Against Pseudomonas Aeruginosa From Cystic Fibrosis Patients
MedChemComm
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Pharmaceutical Science
Drug Discovery
Development of Levofloxacin Inhalation Solution to Treat Pseudomonas Aeruginosa in Patients With Cystic Fibrosis
Therapeutic Advances in Respiratory Disease
Pulmonary
Respiratory Medicine
Pharmacology
